Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety, Tolerability and Transthyretin Stabilization by AG10: A Phase 2, Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients with Transthyretin Amyloid Cardiomyopathy and NYHA Class II/III Heart Failure Judge, D. P., Falk, R., Grogan, M., Heitner, S. B., Jacoby, D., Maurer, M., Selby, V. N., Shah, S. J., Witteles, R. M., Hanna, M., Patel, J., Nativi-Nicolau, J., Rao, S., Sinha, U., Fox, J. C. LIPPINCOTT WILLIAMS & WILKINS. 2018: E770
View details for Web of Science ID 000453713500038